Skip to the content

REVOLUTIONIZING TREATMENT DECISIONS

Home
Solutions
Resources
About
Careers

Home
Solutions
Resources
About
Careers

Our resources

Blogs

All
Podcast
Webinar

Why patient-centric design is the future of oncology trials

Why patient-centric design is the future of oncology trials

Enhancing Patient-Centric Clinical Trials with the Net Treatment Benefit Methodology

Enhancing Patient-Centric Clinical Trials with the Net Treatment Benefit Methodology

More insight from fewer patients: advancing rare disease trials with the Net Treatment Benefit

More insight from fewer patients: advancing rare disease trials with the Net Treatment Benefit

Patient priorities must shape trial design

Patient priorities must shape trial design

Beyond Traditional Endpoints: a patient-focused approach to enhancing rare disease trials

Beyond Traditional Endpoints: a patient-focused approach to enhancing rare disease trials

From frustration to innovation: Marc Buyse’s Mission with One2Treat

From frustration to innovation: Marc Buyse’s Mission with One2Treat

Net Treatment Benefit: A Patient-Focused Assessment of Treatment Effects for Rare Diseases

Net Treatment Benefit: A Patient-Focused Assessment of Treatment Effects for Rare Diseases

Women in Science: Emilie Barré on her passion for applying data to real-world challenges

Women in Science: Emilie Barré on her passion for applying data to real-world challenges

Transforming research through patient-centric design and innovation

Transforming research through patient-centric design and innovation

Net Treatment Benefit: A Patient-Centered Approach to Composite Endpoints

Net Treatment Benefit: A Patient-Centered Approach to Composite Endpoints

Challenges in Oncology Trials: Analyzing Endpoints

Challenges in Oncology Trials: Analyzing Endpoints

The key pharmaceutical trends from 2023 according to industry leaders

The key pharmaceutical trends from 2023 according to industry leaders

« Previous

1
2
3

Next »

Want to invest in a more holistic understanding
of net treatment benefit?

Get in touch

SOLUTIONS

Patient Centric Clinical Trial Design
Inform Dose Optimization
Benefit Risk Assessment

ABOUT

About One2Treat
One2Treat’s Team
Contact

RESOURCES

Learn more about Net Treatment Benefit
Case studies
Regulatory submissions
PRs, podcasts & webinars
Scientific papers

Copyright © 2026 One2Treat
Privacy Policy

Manage Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}